Pfizer Inc. buy BMO Capital Markets
Start price
02.05.24
/
50%
€25.92
Target price
02.05.25
€33.67
Performance (%)
-17.81%
End price
03.05.25
€21.30
Summary
This prediction ended on 03.05.25 with a price of €21.30. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.81%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 4.337% | 4.337% | 8.443% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $36.00 price target on the stock, up previously from $33.00.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten